Innate Pharma S.A. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Innate Pharma S.A. with three other
companies in this sector in France:
sales of 5.58 million Euro [US$5.98 million]
(22.51 million Euro [US$24.13 million]
(8.11 million Euro [US$8.69 million]
of which 100%
was RNA Interference).
Sales increased substantially in 2015:
Innate Pharma S.A. reported sales of 17.91 million Euro (US$19.19 million)
December of 2015.
increase of 1,874.2%
versus 2014, when the company's sales were 907,000.00 Euro.